Zydus receives USFDA tentative approval for Vardenafil Hydrochloride Tablets USP

Zydus Cadila has received the tentative approval from the USFDA to market Vardenafil Hydrochloride Tablets (US RLD-Levitra) in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg. The drug is an erectile dysfunction agent that works by blocking a certain enzyme (phosphodiesterasePDES) used to treat erectile dysfunction (impotence). It will be manufactured at the group's formulations manufacturing facility at SEZ.

Powered by Capital Market - Live News